ProCE Banner Activity

The Role of Monoclonal Antibodies in COVID-19 Prophylaxis and Treatment: Questions and Answers

Clinical Thought
Expert faculty answer the most compelling questions from the live ProCE symposium titled “Emerging Insights on the Role of Monoclonal Antibodies in Patients With COVID-19.”

Released: December 08, 2021

Expiration: December 07, 2022

Share

Faculty

Arun Mattappallil

Arun Mattappallil, PharmD

Clinical Pharmacist Specialist, Infectious Diseases
Department of Pharmaceutical Services
University Hospital
Newark, New Jersey

Jessica K. Ortwine

Jessica K. Ortwine, PharmD, BCIDP

Clinical Assistant Professor
Department of Internal Medicine
University of Texas Southwestern
Infectious Diseases Clinical Pharmacy Specialist
Department of Pharmacy
Parkland Health & Hospital System
Dallas, Texas

Provided by

Provided by ProCE, LLC
ProCE Banner

Supporters

This activity is supported by an educational grant from

GlaxoSmithKline

Partners

SIDP

ProCE Banner

SIDPEC

ProCE Banner

Faculty Disclosure

Primary Author

Arun Mattappallil, PharmD

Clinical Pharmacist Specialist, Infectious Diseases
Department of Pharmaceutical Services
University Hospital
Newark, New Jersey

Arun Mattappallil, PharmD, has disclosed that he has an ownership interest in Relief Therapeutics.

Jessica K. Ortwine, PharmD, BCIDP

Clinical Assistant Professor
Department of Internal Medicine
University of Texas Southwestern
Infectious Diseases Clinical Pharmacy Specialist
Department of Pharmacy
Parkland Health & Hospital System
Dallas, Texas

Jessica K. Ortwine, PharmD, BCIDP, has no relevant conflicts of interest to report.